Member Companies

Bluefors

Bluefors builds the world’s most accessible, innovative and reliable cooling solutions for quantum technology. Our systems are relied upon by thousands of scientists to cool bright ideas into reality.

Cell Therapy

Cell Therapy, LLC is a life sciences company focused on regenerative medicine products to treat neurological ailments. Our stem cells are manufactured for the treatment of spinal cord injury and stroke and have future applications in neuro-degenerative diseases such as Parkinson’s Disease, Alzheimer’s disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis or ALS.

Chem-Impex

At Chem-Impex, we’re more than a chemical supplier—we’re a partner in discovery. Founded in 1981 and still family-owned, we provide over 32,000 research chemicals with fast, dependable delivery and expert support.  We’re especially known for our deep expertise in peptide chemistry, supplying the building blocks, unusual amino acids, resins, and reagents that power today’s most exciting therapeutic and research breakthroughs.  Whether you’re scaling a new therapeutic platform or running an academic lab, our team is here to help you move faster with confidence—offering not just products, but the guidance and reliability you need to translate bold ideas into results.

Exactics

Exactics is a biotech startup founded by innovators from UChicago and Tulane, leveraging its proprietary diagnostic platform to accelerate the development of rapid at-home tests at a fraction of traditional costs. The company’s flagship product — the first truly at‑home rapid test for Lyme disease — serves as a scalable proof of concept, with expansion underway across multiple infectious diseases. The Exactics mission is to make rapid diagnostics affordable and accessible, because early detection shouldn’t be a privilege.

HaloGen

HaloGen, an MIT spinout, is developing a new class of high-energy, non-rechargeable battery for medical and IoT devices.

Kossmek

Kossmek Biosciences is a preclinical biotherapeutic company dedicated to leveraging its discovery of a novel class of highly specific cancer biomarkers and its cutting-edge synthetic antibody pipeline to engineer, design, and develop innovative biologics. These biologics are precisely targeted at tumor-associated proteins, aiming to harness the immune system while minimizing toxicity to healthy tissues.

memQ

memQ, a spin-out from the University of Chicago and Argonne National Lab, developing quantum networking technologies. Quantum networks allow quantum computers to connect, collaborate, and cooperate without collapsing the quantum state. This demands a new, extensible quantum networking architecture (xQNA) capable of scaling to manage qubit entanglement across chips, nodes, racks, and continents. memQ has taken the lead in developing a commercially feasible xQNA. This architecture not only supports multiple qubit modalities but uniquely leverages existing silicon production and telecom infrastructure, massively reducing risk while maximizing speed to market.

Neuro Innovations

Neuro-Innovations, LLC (NI) is a start-up bringing together leading experts in data science and informatics as well as clinical experts in surgical outcomes and medical device development. NI is the bridge between complex data analytics and actionable insight.

Quantum Machines

Quantum Machines is a leading provider of quantum control solutions, driving the advancement of quantum computing with its Hybrid Control approach. By harmonizing quantum and classical operations, Hybrid Control eliminates friction and optimizes performance across hardware and software, enabling researchers and builders to iterate at speed, resolve setbacks, and bring visionary ideas to life. Its platform supports any type of quantum processor, empowering the industry to scale systems, accelerate breakthroughs, and push the boundaries of what’s possible.

Signl

Signl is a biotechnology company that customizes immune responses to provide specific control over the immune system in new ways. Co-founders Professor Aaron Esser-Kahn and Dr. Jeremiah Kim are scientists from the University of Chicago who discovered a landscape of immunomodulatory small molecule compounds. Our first product looks to decouple the inflammatory response of a vaccine with its overall efficacy, leading to vaccines that are more protective and more durable while reducing inflammatory side effects.

StaC12

staC12 is at the forefront of diamond integration technology. By providing diamond in an integrated format, staC12 seeks to provide quantum and semiconductor device makers an easy solution to leverage the potential of diamond for next generation technologies. staC12’s founding team has over 50 years of combined expertise in diamond growth, integration, and applications.

Theta Neurotech

At Theta Neurotech, we’re dedicated to empowering individuals with epilepsy and seizure disorders. Our goal is to provide timely alerts and greater control, transforming the unpredictable nature of seizures into something more manageable. We work tirelessly to develop innovative solutions that bring peace of mind and improve the quality of life for those affected by seizure disorders.

ZipBionexus Technology

ZipBionexus Technology Inc. aims to develop next-generation high-throughput drug screening platforms to make drug discovery faster, cheaper, more accurate, and able to target “undruggable” proteins.